Hillhouse-Backed Biotech Firm Jacobio Plans Hong Kong IPO

(Bloomberg) -- Jacobio Pharmaceuticals Co., a Chinese biotechnology company focusing on cancer treatments, is planning a Hong Kong initial public offering as soon as this year, according to people ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.